Marrone Bio Innovations
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Marrone Bio Innovations generated cash of -$9,961,000, which is more than the previous year. Cash used in financing activities reached the amount of $15,586,000 last year. Net change in cash is therefore $3,782,000.
Cash Flow
| 2012 | -22.42M | -757K | 30.97M |
|---|---|---|---|
| 2013 | -34.00M | -17.67M | 66.13M |
| 2014 | -35.93M | 671K | 46.13M |
| 2015 | -36.17M | -1.64M | 22.33M |
| 2016 | -24.30M | -209K | 14.28M |
| 2017 | -21.05M | -814K | 13.04M |
| 2018 | -19.42M | -580K | 36.95M |
| 2019 | -21.33M | -6.79M | 16.16M |
| 2020 | -15.95M | -1.79M | 27.34M |
| 2021 | -9.96M | -1.84M | 15.58M |
MBII Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 17.40M | 7.81M | 19.78M | 2.83M | 9.60M | 19.83M | 35.32M | 24.45M | 10.00M | 2.21M |
Operating activities | ||||||||||
Net income | -16.55M | -53K | -37.17M | -20.21M | -30.92M | -31.07M | -43.72M | -51.65M | -28.48M | -38.79M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.56M | 3.55M | 3.15M | 1.89M | 2.04M | 2.23M | 3.51M | 2.58M | 976K | 613K |
Stock-based compensation expense | 3.35M | 3.59M | 3.68M | 1.85M | 2.11M | 2.66M | 3.81M | 4.55M | 2.3M | 662K |
| Deferred income tax benefit | 3.35M | 3.59M | 3.68M | 1.85M | 2.11M | 2.66M | 3.81M | 4.55M | 2.3M | 662K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -3.09M | -4.18M | -2.62M | 1.06M | -193K | -1.24M | -560K | 2.9M | -4.14M | -2.52M |
Inventories | -1.98M | 1.53M | 599K | 1.60M | -1.34M | 582K | 3.58M | 73K | -6.79M | -1.62M |
Accounts payable | 585K | -1.40M | 1.20M | -2.02M | 2.30M | -588K | -3.48M | 1.66M | 1.68M | 1.17M |
Cash generated by operating activities | -9.96M | -15.95M | -21.33M | -19.42M | -21.05M | -24.30M | -36.17M | -35.93M | -34.00M | -22.42M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -49K | -17.47M | 0 |
Investments In Property Plant And Equipment | -1.09M | -559K | -296K | -580K | -849K | -209K | -1.65M | -13.00M | -4.02M | -2.75M |
Acquisitions Net | 0 | 0 | -6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.84M | -1.79M | -6.79M | -580K | -814K | -209K | -1.64M | 671K | -17.67M | -757K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 34.48M | 8.18M | 0 | 0 | 39.94M | 56.10M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -37.84M | -524K | 0 | -21.3M | 0 | -1.08M | 0 | -6.13M | -12.54M | -1.86M |
Cash used in financing activities | 15.58M | 27.34M | 16.16M | 36.95M | 13.04M | 14.28M | 22.33M | 46.13M | 66.13M | 30.97M |
Net Change In Cash | 3.78M | 9.58M | -11.96M | 16.94M | -8.82M | -10.22M | -15.48M | 10.86M | 14.44M | 7.79M |
Cash at end of period | 21.18M | 17.40M | 7.81M | 19.78M | 786K | 9.60M | 19.83M | 35.32M | 24.45M | 10.00M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |